Results 231 to 240 of about 8,764,812 (280)
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
The effects of velocity-based vs. percentage-based resistance training on sports performance in trainedindividuals: a systematic review and meta-analysis. [PDF]
Wang Y +5 more
europepmc +1 more source
Cognitive consequences of COVID-19 infection: current evidence and future directions. [PDF]
Hampshire A.
europepmc +1 more source
DDA-bench: a manually curated database for benchmarking datasets and baseline performance values in predicting drug-disease associations. [PDF]
Xing H, Zhao Y.
europepmc +1 more source
The effect of remote ischemic preconditioning on upper extremity strength in healthy male adults: an updated systematic review and meta-analysis. [PDF]
Li J +7 more
europepmc +1 more source
Variation in Variation Measurement: A Mapping Review of Methods to Study Clinical Variation. [PDF]
Quinn AE +11 more
europepmc +1 more source

